Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8813113rdf:typepubmed:Citationlld:pubmed
pubmed-article:8813113lifeskim:mentionsumls-concept:C0017296lld:lifeskim
pubmed-article:8813113lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:8813113lifeskim:mentionsumls-concept:C0034538lld:lifeskim
pubmed-article:8813113lifeskim:mentionsumls-concept:C1658953lld:lifeskim
pubmed-article:8813113lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:8813113lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:8813113lifeskim:mentionsumls-concept:C1883709lld:lifeskim
pubmed-article:8813113pubmed:issue19lld:pubmed
pubmed-article:8813113pubmed:dateCreated1996-11-21lld:pubmed
pubmed-article:8813113pubmed:abstractTextIntratumoral injection of an adenoviral vector containing radiation-inducible DNA sequences of the Egr-1 promoter linked to a cDNA encoding tumor necrosis factor (TNF) alpha (Ad.Egr-TNF) enhances the tumoricidal action of ionizing radiation in a human epidermoid carcinoma xenograft (SQ-20B). The dominant histopathological feature in tumor-bearing animals treated with Ad.Egr-TNF and irradiation is extensive intratumoral vascular thrombosis and tumor necrosis. Thrombosis and necrosis are not observed in animals treated with either the viral construct encoding TNF-alpha or radiation and did not occur in irradiated normal tissues adjacent to tumor in animals injected with Ad.Egr-TNF. To determine if the occlusive effects of Ad.Egr-TNF and X-irradiation were specific for tumor vessels, non-tumor-bearing mice were irradiated after receiving i.m. injection of Ad.Egr-TNF at viral titers 20-100 times greater than titers injected intratumorally. No vascular thrombosis was observed in the treated normal tissues. Combined Ad.Egr-TNF and radiation produced occlusion of tumor microvessels without significant normal tissue damage. Taken together, these data suggest that the interaction between radiation inducible TNF-alpha and X-irradiation occurs selectively within the tumor vessels.lld:pubmed
pubmed-article:8813113pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8813113pubmed:languageenglld:pubmed
pubmed-article:8813113pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8813113pubmed:citationSubsetIMlld:pubmed
pubmed-article:8813113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8813113pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8813113pubmed:statusMEDLINElld:pubmed
pubmed-article:8813113pubmed:monthOctlld:pubmed
pubmed-article:8813113pubmed:issn0008-5472lld:pubmed
pubmed-article:8813113pubmed:authorpubmed-author:HellmanSSlld:pubmed
pubmed-article:8813113pubmed:authorpubmed-author:WeichselbaumR...lld:pubmed
pubmed-article:8813113pubmed:authorpubmed-author:HallahanD EDElld:pubmed
pubmed-article:8813113pubmed:authorpubmed-author:WayneJ DJDlld:pubmed
pubmed-article:8813113pubmed:authorpubmed-author:MauceriH JHJlld:pubmed
pubmed-article:8813113pubmed:authorpubmed-author:HannaN NNNlld:pubmed
pubmed-article:8813113pubmed:issnTypePrintlld:pubmed
pubmed-article:8813113pubmed:day1lld:pubmed
pubmed-article:8813113pubmed:volume56lld:pubmed
pubmed-article:8813113pubmed:ownerNLMlld:pubmed
pubmed-article:8813113pubmed:authorsCompleteYlld:pubmed
pubmed-article:8813113pubmed:pagination4311-4lld:pubmed
pubmed-article:8813113pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:meshHeadingpubmed-meshheading:8813113-...lld:pubmed
pubmed-article:8813113pubmed:year1996lld:pubmed
pubmed-article:8813113pubmed:articleTitleTumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.lld:pubmed
pubmed-article:8813113pubmed:affiliationDepartment of Radiation and Cellular Oncology, Pritzker School of Medicine, University of Chicago, Illinois 60637, USA.lld:pubmed
pubmed-article:8813113pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8813113pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8813113pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8813113lld:pubmed